Journal Articles

Learning from COVID-19: developing a more efficient tissue viability service

Share this article

Learning from COVID-19: developing a more efficient tissue viability service

Heidi Sandoz, Jacqui Fletcher, Karen Ousey, Leanne Atkin, Lesley Newport, Nina Murphy
27 September 2020

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus (World Health Organization [WHO], 2020). A pandemic has been declared by the World Health Organization, which is defined as ‘an epidemic that is spread over several countries or continents and affects.

Free for all healthcare professionals

Sign up to the Wounds Group journals





By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.